Material Transfer Agreement. (For Use for For-Profit Research Purpose) RECIPIENT Recipient Scientist (Principal Investigator): Recipient Organization: Address: This Material Transfer Agreement sets forth the terms and conditions under which RIKEN BioResource Research Center (hereinafter referred to as ‘RIKEN BRC’) will provide with the RECIPIENT, and the RECIPIENT will receive, the biological material specified as (RIKEN BRC No. ) and its derivatives (hereinafter referred to as the ‘BIOLOGICAL RESOURCE’) in response to the RECIPIENT’s request, and with which the RECIPIENT scientist and organization agree before the RECIPIENT receives the BIOLOGICAL RESOURCE:
Material Transfer Agreement. The Material Transfer Agreement executed by the parties shall remain in effect.
Material Transfer Agreement. A true and complete copy of the Material Transfer Agreement (“MTA”) with University of Colorado Health Sciences Center (“UCHSC”) is attached hereto as Exhibit 3. Licensee shall provide copies of any revisions or modifications of such MTA and any new material transfer agreements or research agreements with UCHSC or University of Colorado within ten (10) days of the execution of such agreements.
Material Transfer Agreement. This Agreement supersedes and replaces that certain Material Transfer Agreement by and between the Parties dated as of [**], as amended (the “Material Transfer Agreement”). All Materials (as such term is defined in the Material Transfer Agreement) delivered to a Party by the other Party under the Material Transfer Agreement shall be deemed Party Materials of the respective providing Party hereunder and shall be so subject to the terms of this Agreement.
Material Transfer Agreement. In response to your request for material from the laboratories of Xx. Xxxxxx Xxxxxx, a Xxxxxx Xxxxxx Medical Institute investigator at Yale University, and Dr. Xxxxx Xxxxx (“the Yale Investigators”), YALE will make the following available to your company, Rib-X Pharmaceuticals, Inc. and its affiliates. (“RECIPIENT”):
Material Transfer Agreement. THIS MATERIAL TRANSFER AGREEMENT ("Agreement") is made and entered into as of May 10th 2016 (the "Effective Date"), by and between DYADIC INTERNATIONAL (USA), INC., a Florida corporation, with its principal place of business at 000 xxxxxxxxxxxx Xxxxxx Xxxxx, Xxxxx 000, Xxxxxxx, XX 00000 ("Dyadic") and the undersigned party ("Recipient").
Material Transfer Agreement. Pursuant to the License Agreement (herein after, the “License Agreement”) to which this Materials Transfer Agreement is attached (hereinafter, the “MTA”), WSU may provide LICENSEE with tangible research materials relating to the Licensed Patents. In the event of any such transfer of materials, LICENSEE agrees as follows:
Material Transfer Agreement. NY is a cosignatory of The Principles on Access to Genetic Resources and Benefit-sharing for Participating Institutions and, thus, expects its collaborators and Recipients to conform to the letter and spirit of the Convention on Biological Diversity. The Recipient will comply with all international and United States national legislation, the legislation of the country from which the specimen originated, and other international protocols and / or agreements, particularly those governing the use of biological and genetic material / heritage, access, and benefit-sharing. Use of the Material (i.e., samples of specimens in the NY Herbarium) as provided by NY to the Recipient and all other parties is restricted to the terms outlined in this document. In compliance with the Nagoya Protocol, the Recipient will track all uses of the Material sampled from specimens housed at NY, and will report these uses (e.g., publications, public database numbers) to NY. The Material has been collected solely for use in academic research on plant, algal, or fungal systematics, molecular phylogenetics, conservation, and evolution, and will be released only for such non-commercial research. The Recipient will not sell, distribute, or use the Material for profit or any other commercial purpose. The Recipient shall acknowledge NY as the source of the Material in all written and electronic publications and reports. The Recipient will provide NY with copies of any resulting publications. The Recipient must submit to GenBank not only the xxxxxxxx xxxx but also essential information about the voucher specimen from which the Material was obtained: collector’s name and collection number, and the NYBG Herbarium (NY) as place of deposit of the specimen. The Recipient must provide NY with a list of specimens from which DNA sequences have been obtained. The Recipient may not transfer the Material or any derivative thereof without prior permission from the Director of NY and then only to a bona fide third party, such as a university or research institution, for non-commercial scientific research. Any transfers are also subject to the conditions of this Agreement, and a new Material Transfer Agreement must be signed by the third party and the Director of the NYBG Herbarium. The Recipient acknowledges that the Material is provided without any warranty. The Recipient hereby indemnifies and holds harmless NY for any liability or expenses incurred by NY as a result of Recipient’s use of the Material...
Material Transfer Agreement. (MTA) Purpose: Agreement governs transfer of biological materials (including human tissues and specimens, genetically modified organisms), chemicals or other materials between parties for research purposes with legal protections for the transferor. Material Transfer Agreements ? What is the first step before you can initiate an MTA • If human subject research is federally supported, there must be a protocol approved by the Institutional Review Board (College Committee if non- federally supported) before an MTA can be executed. • If research using recombinant-DNA, Biohazards and Bloodborne Pathogens, there must be a protocol approved by the Institutional Biosafety Committee before an MTA can be executed. • If animal research is involved, there must be a protocol approved by the Institutional Animal Care and Use Committee (IACUC) before an MTA can be executed. Material Transfer Agreements Nexus between Research Protocol reviews and MTAs ▶ Certain material are part of research protocols that are subject to prior approval by university review committees (e.g. Institutional Biosafety Committee, Institutional Animal Care and Use Committee, Institutional Review Board or Radiation Safety Committee). ▶ Only after the material has been approved by the appropriate university review committee/board, if applicable, can the MTA be initiated and executed. ▶ The MTA must either specify or define the material within the body of the MTA or in a signed exhibit that is part of the MTA. Future additions to the approved material list will require a signature by the Vice President of Research. Material Transfer Agreements What is covered “material”? Material Transfer Agreement clearly specifies and defines the material. Note: If a vendor supplying the materials does not request an MTA, then ODU does not request an MTA. The specification of material is typically required in an MTA if the vendor requires an MTA. For biological materials – typically includes: • original material • progeny - descendent from the material – e.g. virus from cell, cell from cell, or organism from organism. • unmodified derivatives - substances created by the recipient which constitute an unmodified functional subunit or product expressed by the Original Material (e.g. subclones of unmodified cell lines, proteins expressed by DNA/RNA supplied by the provider, monoclonal antibodies secreted by a hybridoma cell line) • Excludes modifications to the original material. Material Transfer Agreements
Material Transfer Agreement. In the event the Test Materials are to be provided by GSK to RGI for the Study, they shall be transferred to RGI under the terms of the Material Transfer Agreement attached hereto as Schedule III.
